A new study by UW–Madison School of Pharmacy researchers reveals the hurdles and unsung efforts of Wisconsin pharmacists during the COVID-19 Test-to-Treat rollout.
A new study by UW–Madison School of Pharmacy researchers reveals the hurdles and unsung efforts of Wisconsin pharmacists during the COVID-19 Test-to-Treat rollout.
Professor Jiaoyang Jiang’s work on protein glycosylation is being recognized with one of UW–Madison’s top faculty honors.
See the people, processes, and equipment behind Assistant Professor Cody Wenthur’s exploration into psychoactive substances.
Created at the UW–Madison School of Pharmacy, Med Wise Rx is helping older adults understand their medications — and advocate for themselves.
The UW–Madison School of Pharmacy’s PearlRx — the nation’s largest research network of its kind — connects pharmacists and researchers to improve Wisconsin practice.
Professor Barry Gidal, a nationally recognized leader in epilepsy research, is driving progress in treatment and patient advocacy.
Professor Lingjun Li and lab members reveal the crucial role of neuropeptides in cocaine addiction, paving the way for novel therapies.
With support from the NIH, Assistant Professor Quanyin Hu uses a two-step system to attack triple-negative breast cancer.
With V Foundation funding, Assistant Professor Quanyin Hu aims to improve a cancer-killing hydrogel to improve outcomes for pediatric GBM patients.
UW researchers find previously unknown links between microbial bile acids and the risk of colon cancer.